Masashi Ishihara

1.0k total citations
53 papers, 744 citations indexed

About

Masashi Ishihara is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Masashi Ishihara has authored 53 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 13 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Masashi Ishihara's work include Nausea and vomiting management (9 papers), Pain Management and Opioid Use (4 papers) and Anesthesia and Pain Management (4 papers). Masashi Ishihara is often cited by papers focused on Nausea and vomiting management (9 papers), Pain Management and Opioid Use (4 papers) and Anesthesia and Pain Management (4 papers). Masashi Ishihara collaborates with scholars based in Japan, United States and India. Masashi Ishihara's co-authors include Mikio Ito, Yoshinori Itoh, Yoshinori Suzuki, Katsuhiko Matsuura, Hirotoshi Iihara, Kazuhiro Yoshida, Tomoko Watanabe, Keisuke Mizuta, Yoshio Suzuki and Hironori Fujii and has published in prestigious journals such as Journal of the American College of Cardiology, Scientific Reports and Annals of Oncology.

In The Last Decade

Masashi Ishihara

49 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masashi Ishihara Japan 14 218 136 126 97 96 53 744
Li‐Wei Chen Taiwan 18 216 1.0× 132 1.0× 95 0.8× 129 1.3× 91 0.9× 61 842
Weiqing Chen China 17 128 0.6× 382 2.8× 164 1.3× 189 1.9× 47 0.5× 65 836
Jean Spénard Canada 15 428 2.0× 95 0.7× 171 1.4× 69 0.7× 70 0.7× 45 971
So Young Yoon South Korea 18 78 0.4× 226 1.7× 165 1.3× 163 1.7× 47 0.5× 59 821
Mohammad Perwaiz Iqbal Pakistan 18 212 1.0× 83 0.6× 53 0.4× 234 2.4× 87 0.9× 102 1.1k
Abdullah Uyanık Türkiye 14 151 0.7× 105 0.8× 68 0.5× 112 1.2× 46 0.5× 64 670
Yiming Zhang China 24 294 1.3× 96 0.7× 84 0.7× 253 2.6× 37 0.4× 96 1.5k
Dongfang Su China 17 139 0.6× 58 0.4× 38 0.3× 253 2.6× 110 1.1× 30 809
M J Sanderson United Kingdom 9 280 1.3× 21 0.2× 154 1.2× 106 1.1× 74 0.8× 11 660
Mehmet Gençer Türkiye 14 70 0.3× 31 0.2× 153 1.2× 115 1.2× 135 1.4× 40 688

Countries citing papers authored by Masashi Ishihara

Since Specialization
Citations

This map shows the geographic impact of Masashi Ishihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Ishihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Ishihara more than expected).

Fields of papers citing papers by Masashi Ishihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Ishihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Ishihara. The network helps show where Masashi Ishihara may publish in the future.

Co-authorship network of co-authors of Masashi Ishihara

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Ishihara. A scholar is included among the top collaborators of Masashi Ishihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Ishihara. Masashi Ishihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Hao, Masashi Ishihara, Yasuko Ichikawa, et al.. (2024). Efficacy and safety of pharmacotherapy for cancer cachexia: A systematic review and network meta‐analysis. Cancer Medicine. 13(17). e70166–e70166. 4 indexed citations
3.
Ishihara, Masashi, et al.. (2024). Factors associated with patient satisfaction with antiretroviral therapy in Japan: A cross-sectional, multicenter study. Journal of Infection and Chemotherapy. 30(8). 746–751. 3 indexed citations
4.
Ishihara, Masashi, et al.. (2024). Factors associated with incomplete adherence to integrase strand transfer inhibitor-containing single-tablet regimen among Japanese people living with HIV. Journal of Pharmaceutical Health Care and Sciences. 10(1). 27–27.
5.
6.
Chen, Hao, Masashi Ishihara, Takahiko Sakamoto, et al.. (2023). Predictors of central line-associated bloodstream infections in cancer patients undergoing chemotherapy through implanted venous access ports: a retrospective, observational study. Translational Cancer Research. 12(12). 3538–3546. 1 indexed citations
7.
Zenke, Yoshitaka, Seiji Niho, Shigeki Umemura, et al.. (2020). Phase I/II study of carboplatin plus weekly nab-paclitaxel in patients aged ≥75 years with squamous-cell lung cancer: TORG1322. Lung Cancer. 146. 182–188. 1 indexed citations
8.
Ichikawa, Yasuko, Masashi Ishihara, Takahiko Sakamoto, et al.. (2019). Carcinoma of Unknown Primary Site: A Mini-Review on Chemotherapy and the Expectation for Treatment with Nab-Paclitaxel Plus Carboplatin. 2(3). 1 indexed citations
9.
Seki, Nobuhiko, Masashi Ishihara, Takahiko Sakamoto, et al.. (2019). Promising Combination Therapy with Bevacizumab and Erlotinib in an EGFR-Mutated NSCLC Patient with MET Amplification Who Showed Intrinsic Resistance to Initial EGFR-TKI Therapy. Case Reports in Oncology. 12(1). 91–97. 6 indexed citations
10.
Seki, Nobuhiko, Masashi Ishihara, Takahiko Sakamoto, et al.. (2019). Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin Rush. Case Reports in Oncology. 12(1). 84–90. 2 indexed citations
11.
Fujii, Hironori, Masashi Ishihara, Hirotoshi Iihara, et al.. (2018). Improvement of Dysgeusia by Polaprezinc, a Zinc-L-carnosine, in Outpatients Receiving Cancer Chemotherapy. Anticancer Research. 38(11). 6367–6373. 18 indexed citations
12.
Honda, Takeshi, Masashi Ishihara, Takahiko Sakamoto, et al.. (2017). A Case of Lung Adenocarcinoma with Marked Improvement of Pulmonary Lymphangitic Carcinomatosis by Adding Bevacizumab to Cisplatin and Pemetrexed. Case Reports in Oncology. 10(3). 1065–1069. 4 indexed citations
13.
Iihara, Hirotoshi, Masashi Ishihara, Katsuhiko Matsuura, et al.. (2011). Pharmacists contribute to the improved efficiency of medical practices in the outpatient cancer chemotherapy clinic. Journal of Evaluation in Clinical Practice. 18(4). 753–760. 48 indexed citations
14.
Ishihara, Masashi, Hirotoshi Iihara, Koji Yasuda, et al.. (2009). Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients. Supportive Care in Cancer. 18(12). 1531–1538. 25 indexed citations
15.
Ohtani, T., Masashi Ishihara, & Satoru Kojima. (2008). A Potential Installation of Groundwater Heat Pump Systems Inferred from Well Information in the Nobi Plain. 30(2). 121–129. 3 indexed citations
16.
Ishihara, Masashi, Ryoji Kojima, & Mikio Ito. (2008). Influence of aging on gastric ulcer healing activities of the antioxidants α-tocopherol and probucol. European Journal of Pharmacology. 601(1-3). 143–147. 11 indexed citations
17.
Ohtaki, Ko‐ichi, Masashi Ishihara, Takashi Ono, et al.. (2005). Analysis of Contraindicated Combinations Using a Check System tor Drug Interactions, Including those of Injections-Pharmacists Should Verify Drug Interactions in Patient Medication Histories. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 31(6). 425–434. 2 indexed citations
18.
Aoyama, Mineyoshi, et al.. (2004). Expression of glia maturation factor beta after cryogenic brain injury. Molecular Brain Research. 133(1). 71–77. 14 indexed citations
19.
Ishihara, Masashi & Mikio Ito. (2002). Influence of aging on gastric ulcer healing activities of cimetidine and omeprazole. European Journal of Pharmacology. 444(3). 209–215. 40 indexed citations
20.
Ito, Mikio, Yoshinori Suzuki, Masashi Ishihara, & Yoshio Suzuki. (1998). Anti-ulcer effects of antioxidants: effect of probucol. European Journal of Pharmacology. 354(2-3). 189–196. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li‐Wei Chen Breakdown of academic impact, for papers by Weiqing Chen Breakdown of academic impact, for papers by Jean Spénard Breakdown of academic impact, for papers by So Young Yoon Breakdown of academic impact, for papers by Mohammad Perwaiz Iqbal Breakdown of academic impact, for papers by Abdullah Uyanık Breakdown of academic impact, for papers by Yiming Zhang Breakdown of academic impact, for papers by Dongfang Su Breakdown of academic impact, for papers by M J Sanderson Breakdown of academic impact, for papers by Mehmet Gençer
Rankless by CCL
2026